| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating expenses | $21.4M+421.2% | $4.1M | — | — | — |
| General and administrative expenses | $14.8M+329.0% | $3.4M+7126.9% | $48K-3.6% | $49K+282.5% | $13K |
| Research and development expenses | $6.6M+900.9% | $661K | — | — | — |
| Operating loss | -$21.4M-421.2% | -$4.1M-8515.2% | -$48K+3.6% | -$49K-282.5% | -$13K |
| Interest income | $211K+937.8% | $20K | — | — | — |
| Change in fair value of SAFE Notes | -$39.8M-2341.6% | -$1.6M | — | — | — |
| Other income | $4K+471.0% | $749 | — | — | — |
| Total non-operating expense | -$39.6M-2360.2% | -$1.6M | — | — | — |
| Net loss | -$61.0M-967.7% | -$5.7M-11896.6% | -$48K+3.6% | -$49K-282.5% | -$13K |
| Basic weighted average shares outstanding of common stock (in shares) | 25.3M+152.4% | 10.0M+100.7% | 5.0M+0.0% | 5.0M+0.0% | 5.0M |
| Diluted weighted average shares outstanding of common stock (in shares) | 10.0M | — | 5.0M | — | — |
| Basic net loss per share of common stock (in dollars per share) | -$2.41-322.8% | -$0.57-5600.0% | -$0.01+0.0% | -$0.01 | $0.00 |
| Diluted net loss per share of common stock (in dollars per share) | -$0.57 | — | -$0.01 | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.